Molina Healthcare’s stock swung dramatically after a steep February earnings-guidance shock and Medicaid adjustments knocked 2026 EPS expectations lower. Short-term rebounds followed amid elevated volume and a shareholder probe, but structural cost pressures and governance questions keep downside risk prominent.
Molina Healthcare (MOH) plunged after a surprise Q4 loss and a dramatic cut to 2026 profit guidance. Operational hits—retroactive Medicaid adjustments, Florida contract implementation costs, a Medicare Advantage exit and a $93M impairment—drove the sell-off and prompted concern about liquidity and margin pressure despite contrarian investor interest.
